163 related articles for article (PubMed ID: 12758097)
1. Developments in drugs for ovarian stimulation.
Ludwig M; Westergaard LG; Diedrich K; Andersen CY
Best Pract Res Clin Obstet Gynaecol; 2003 Apr; 17(2):231-47. PubMed ID: 12758097
[TBL] [Abstract][Full Text] [Related]
2. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
3. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
[TBL] [Abstract][Full Text] [Related]
4. Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women.
Laml T; Obruca A; Fischl F; Huber JC
Gynecol Endocrinol; 1999 Apr; 13(2):98-103. PubMed ID: 10399054
[TBL] [Abstract][Full Text] [Related]
5. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
Dahan MH; Agdi M; Shehata F; Son W; Tan SL
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
[TBL] [Abstract][Full Text] [Related]
6. Benefits of luteinizing hormone activity in ovarian stimulation for IVF.
Venetis CA; Kolibianakis EM; Tarlatzi TB; Tarlatzis BC
Reprod Biomed Online; 2009; 18 Suppl 2():31-6. PubMed ID: 19406029
[TBL] [Abstract][Full Text] [Related]
7. Use of gonadotrophin-releasing hormone agonists to trigger ovulation.
Tay CC
Hum Fertil (Camb); 2002 Feb; 5(1):G35-7; discussion G38-9, G41-8. PubMed ID: 11939159
[TBL] [Abstract][Full Text] [Related]
8. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
9. Basic understanding of gonadotropin-releasing hormone-agonist triggering.
Casper RF
Fertil Steril; 2015 Apr; 103(4):867-9. PubMed ID: 25712575
[TBL] [Abstract][Full Text] [Related]
10. The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction.
Zafeiriou S; Loutradis D; Michalas S
Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):157-67. PubMed ID: 10943580
[TBL] [Abstract][Full Text] [Related]
11. FSH and folliculogenesis: from physiology to ovarian stimulation.
Vegetti W; Alagna F
Reprod Biomed Online; 2006 Jun; 12(6):684-94. PubMed ID: 16792843
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of recombinant LH supplementation in patients with suboptimal response to recombinant FSH undergoing IVF treatment with GnRH agonist down-regulation.
Yazıcı Yılmaz F; Görkemli H; Çolakoğlu MC; Aktan M; Gezginç K
Gynecol Endocrinol; 2015 Feb; 31(2):141-4. PubMed ID: 25237892
[TBL] [Abstract][Full Text] [Related]
13. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up.
Kolibianakis E; Bourgain C; Albano C; Osmanagaoglu K; Smitz J; Van Steirteghem A; Devroey P
Fertil Steril; 2002 Nov; 78(5):1025-9. PubMed ID: 12413988
[TBL] [Abstract][Full Text] [Related]
14. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
15. GnRH antagonists in ovarian stimulation for IVF.
Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
[TBL] [Abstract][Full Text] [Related]
16. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
17. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
[TBL] [Abstract][Full Text] [Related]
18. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
[TBL] [Abstract][Full Text] [Related]
19. Ovarian stimulation for in-vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: agonists and antagonists.
Felberbaum R; Diedrich K
Hum Reprod; 1999 Sep; 14 Suppl 1():207-21. PubMed ID: 10573035
[TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
